Home About Us Contact Us

 

Table of Content - Volume 8 Issue 3 - December 2017



A cross sectional follow-up study of kidney donors in a tertiary care centre from south India

 

Shivakumar Dakshinamoorthy1, Murugesan V2*

 

1,2Assistant Professor, Department of Nephrology, Kilpauk Medical College and Government Royapettah Hospital Chennai, INDIA.

Email: dshiva1978@gmail.com

 

Abstract              Background: Living renal donors form the major pool of kidney transplantation in India. Even though many studies have demonstrated the safety of living renal donation there is always a concern about safety of renal donors. Materials and method: This was a cross sectional study conducted at Govt. Kilpauk Medical college hospital and Government Royapettah Hospital attached to Govt. Kilpauk Medical College, Chennai. Thirty living related renal donors were included in the study. Their case records were examined for immediate and long term complications. They were examined for HT, IFG, proteinuria, microscopic hematuria. Remnant kidney size was measured using ultra sonogram. Their GFR values were calculated using Cockcroft- Gault, a MDRD and CKD- EPI creatinine formulae. GFR was measured by Tc 99 DTPA isotope scan. Their kidney sizes, calculated and measured GFR were compared with pre-nephrectomy values. Correlation between calculated and measured GFR was assessed. Results: Two donors had hypertension. Five donors had IFG. Two had sub nephrotic proteinuria. Eleven donors had anemia. One developed CKD due to glomerular disease. One died because of malignancy. Donors had expected increase in measured GFR. There were no correlations between calculated eGFR and measured GFR. Conclusion: Even though living renal donation is a safe procedure regular follow up of donors and insistence on life style modifications during each visit is important.

Key Word: Renal donors, measured GFR, e GFR, CKD, proteinuria HT ,IFG.

 

INTRODUCTION

Kidney transplantation is the best renal replacement modality for ESRD patients. The source of transplant kidney can be either from living or cadaver donors. In India where 3000 – 4000 renal transplantations take place annually, the donor pool is mainly from living donors who are mostly related to the recipient. In a few states viz. Tamilnadu, Gujarat and Maharashtra, deceased donors form a significant percentage of renal transplantation. Even then cadaver donors contribute 2% of the total renal transplantation only. After donating a kidney, the remaining kidney increases its function to compensate for its lost pair. In a short time after donation, the total GFR of the single kidney reaches 70 - 80% of the total GFR due to hyperfiltration and increased renal parenchymal volume(RPV). There have been several studies that have been reassuring and some studies revealing the risks acquired due to donation. This is yet another study on South Indian kidney donor population.

 

MATERIALS AND METHOD

This was a cross- sectional study conducted at Govt. Kilpauk Medical college hospital and Govt. Royapettah Hospital, attached to Govt. Kilpauk Medical College, Chennai. At present about 40 living related renal recipients are attending renal transplant follow up clinic at our centres. The renal donoŕs who have completed 3 months of post-operative period were included in this study. Of these one donor had died of uterine malignancy. One developed CKD due to glomerular disease. Six did not give consent. Two could not be traced. Thirty donors were included in our study. Their case records were analysed for immediate and long term complications. Their BP was measured at least on 3 occasions to detect HT.FBS was measured. They underwent urine examination to detect proteinuria and hematuria. Serum creatinine was done by modified Jaffe’s method. Ultrasonogram was done to measure transplant kidney size. Their eGFR was calculated by Cockcroft-Gault, aMDRD, CKD-EPI equations. Their GFR was measured by Tc 99- DTPA isotope scan. Kidney sizes, eGFR and measured GFR were compared with corresponding pre transplant values. Correlation between GFR and measured GFR was done for both pre transplant and post-transplant values. Statistical Analysis was done using SPSS version 19.0 and p < 0.05 was taken as statistical significance.

 

RESULTS

The earliest period of evaluation was 4 months post- transplant and the longest period was 156 months and median period of follow-up was 29 months (IQR 22.75). Of the 30 donors, 22 (73.3%) were females and 8 (26.7%) were males.

 

Table 1: The age distribution of donors was as follows

Age group (years)

Number

Percentage

18 – 29

1

3.3

30 – 39

7

23.3

40 – 49

14

46.7

> 50

8

26.7

 

The eldest donor was 58 years old at the time of donor nephrectomy and the youngest donor was aged 24. Immediate post-operative complications: Five donors (16%) had immediate post–operative complications. Two had atelectasis which improved with spirometry and chest physiotherapy. Two donors developed pneumonia which required escalation of antibiotics and prolonged hospital stay. One donor developed wound dehiscence requiring secondary suturing. No deaths occurred in the post-surgical period. Long term complications: One died because of uterine malignancy 2 years post donation. One developed CKD due to IgA nephropathy with crescents. Comparison of pre and post donation investigations The mean systolic BP was 119.53 and 119.50 mm of Hg pre and post-donation respectively and mean diastolic BP was 78.13 and 78.80 mm of Hg pre-donation and post-donation respectively. Two donors (6.7%) developed hypertension as defined by JNC 7after two years, one at stage 1 and another at stage 2. The mean Hb pre-donation was 11.40% and it was 11.13% post-donation. Eleven had anemia. There was a marginal rise in proteinuria from 0.12 to 0.17 post-donation. Two developed sub nephrotic proteinuria (PCR 0.4, 1). None developed microscopic hematuria post-donation. Mean FBS pre and post donation were 84.5 and 91.9 mg/dl respectively (p 0.001).Five of the donors developed IFG. Mean serum creatinine pre and post donation were 0.84 and 1.01respectively (p 0.001). Kidney length and width were measured using ultrasound and kidney size was calculated and compared with pre donation values. The depth was not measured and hence, renal parenchymal volume could not be calculated.


Mean kidney length(mm)

Mean kidney width(mm)

Mean kidney size(mm2)

Pre-donation

Post-donation

Increment

Pre-donation

Post-donation

Increment

Pre-donation

Post-donation

Increment

98.77

108.5

9.73

41.17

46.53

5.37

4082.8

5082

999.20

p 0.001

p 0.001

p 0.001

eGFR(ml/min/1.73 m2) was calculated by CG formula, aMDRD and CKD EPI creatinine equation, pre and post donation.

 

eGFR by C-G formula (ml/ min/ 1.73 m2)

eGFR by aMDRD formula (ml/ min/ 1.73 m2)

eGFR by CKD-EPI formula (ml/ min/ 1.73 m2)

Pre-donation

Post-donation

Decrement

Pre-donation

Post-donation

Decrement

Pre-donation

Post-donation

Decrement

97.93

72.47

15.46

84.34

66.97

17.37

93.17

75.17

18

p 0.001

p 0.001

p 0.001

 

GFR measured by 99mTc DTPA pre and post-donation

Total GFR by DTPA

Mean

SEM

Mean difference

T value

P value

Pre

102.53

1.70

21.76

11.715

0.001

Post

80.77

1.14

Correlation of eGFR vs GFR measured by 99mTc DTPA Pearsons correlation was used to analyze the correlation between eGFR calculated by different equations and that measured by 99mTc DTPA, pre and post donation. They are shown by the images below, along with the correlation coefficient r and its p value.

 


 

 

Figure 1: Egfr By Cg Vs Total Gfr By 99mtc - Dtpa (Pre-Donation)

Correlation coefficient r = 0.331, p = 0.074

 

Figure 2: eGFR by CG vs 99mTc - DTPA GFR (post donation)

r = 0.071, p = 0.709

 

Figure 3: eGFR by aMDRD vs 99mTc DTPA GFR (pre-donation)

r = 0.291, p = 0.119

 

Figure4: eGFR by aMDRD vs 99mTc DTPA GFR (post donation

r = 0.164, p = 0.385

 

Figure 5: eGFR by CKD EPI vs 99mTc - DTPA GFR(pre-donation)

R = 0.340, p = 0.066

Figure 6: eGFR by CKD EPI vs 99mTc – DTPA GFR (post donation)

r = 0.254, p = 0.175

 

Table 1: Increase in measured GFR by 99mTc DTPA in remnant kidney

DTPA total gain

Mean

SEM

Mean difference

T value

P value

Pre single kidney GFR

50.87

1.11

-29.90

-22.182

0.001

Post

80.77

1.14

The increase in GFR is more in younger age group (r = -0.362, p = 0.05). Kidney size had no correlation with measured GFR, both pre and post donation (R = 0.142, p = 0.455).

 

DISCUSSION

Living renal donation forms the source of more than 95 percent of renal transplantations in India. They transform the lives of numerous ESRD patients by their generosity and selfless attitude. Most of them are related to their recipients. Being aware of the morbidity and mortality of CKD patients, most of the donors take good care of themselves to avoid the risk factors for development of CKD. In our study of 30 donors, 22 were females (73.3%) and 8 were males (26.7%). There were 16 male recipients (53%) and 14 female recipients (47%). Most of the donors were females while most of the recipients were males. This is similar to the observation in studies by Biller et al1 from Germany and Zimmermann et al2 from Canada. It has been hypothesized that females think it is their duty to relieve the suffering of their spouse or children. In our study, of the 22 female donors, 13 donated to their children, 6 to their husbands and 3 to their brothers. Of the 8 male donors, 4 donated to their children, 2 to their wives and 2 to their siblings. So 56.6% donors were parents, 26.6% spouses and 16.6% siblings. Peri – operative complications are relatively common3 in renal transplantation and Blohmel demonstrated atelectasis (13.5%), prolonged ileus (5.2%), pneumonia (4.5%) and urinary tract infection (4.3%). In our centre, open nephrectomy is done and the mean period of hospital stay is 6 to 7 days. In our study 2 developed basal atelectasis (6%). Two donors developed pneumonia (6%) with necessity for escalation of antibiotics. One donor developed wound dehiscence (3%) which required secondary suturing and prolongation of hospital stay. The surgical mortality in donor nephrectomy is reported to be 0.03%by Segev4. In our study surgical mortality was nil. Though there was increase in spot protein creatinine ratio, from 0.13 to 0.17, it was not statistically significant. Two (6.6%) developed subnephrotic proteinuria. Similar studies show that incidence of proteinuria is about 3% to 24%5,6,7,8,9. Tapson observed 3% proteinuria at 10 years and 0% at 20 years (5). Natarajan observed 23% proteinuria in donors and 22% in their siblings10. Though late proteinuria has been reported that has not been linked to the progression of renal disease4. None of the donors in our study had microscopic hematuria. Though there was no statistical significance in Hemoglobin levels before and after renal donation, eleven donors had developed anemia post donation. Their peripheral smear study revealed microcytic hypochromic anemia. They improved with oral iron. Bertram l.Kasiske11 observed 3.7% reduction of Hb in 194 donors in 8 US transplant centres 6 months post-donation. The concerning issue was the development of impaired fasting glucose in 5 donors (16.5%). Four of them were overweight. The earliest period to development was 1 year post donation and latest was 6 years. H. N. Ibrahim12 observed154 (17.7%) T2DM from 2954 donors 9 years after donation. Imed H et al observed 8.4% T2DM in 284 Tunisian donors13. Two (6.6%) donors developed hypertension 2 years post donation. One was in JNC Stage 1and other in JNC Stage 2. Both were obese. The incidence of hypertension in donors has been reported to be the same as in general population. Similar studies report incidence of hypertension in renal donors between 7% to 47%5,6,7,8,9,14. Tapson5 observed 13% incidence of HT at 10 years and 38% at 20 years. Williams14 observed 47% incidence of HT in donors vs 35% in siblings, equal (42%) incidence of HT in male donors and age, race matched male controls and 50% incidence of HT in female donors comparing to 31% in female controls. One out of 30 donrs (2.7%) in our centres developed CKD due to IgA nephropathy with crescents. Hartmaan A and Holdaas H observed 7 cases of ESRD in 1800 donors and mostly due to primary kidney disease and not due to HT or hyperfiltration15,16. In similar studies incidences of CKD were between 2% to 12% 17,18,19. Ellison20 observed incidences of ESRD were similar between donors (0.04%) and general population (0.03%). One died of uterine malignancy 2 years post-transplant. Fehrman-Ekholm21 observed 41 deaths in 430 donors between 15 months and 31 years in Sweden, majority due to cardiac disease and malignancy. The compensatory hyperfiltration by the remnant kidney leads to a maximum of 70% of pre-donation GFR in about 6 months. There was a mean 29.90(16 – 41ml/min/1.73 m2) increase in the remnant kidney due to compensatory hyperfitration. The higher range of rise in GFR was seen with younger donors. This is similar to the observation reported in literature22. The other side of it, kidney donation leads to loss of total GFR by 30%. In our study, there were 0.17 increases in serum creatinine post donation (p 0.001). The rise in creatinine resulted in statistically significant fall in estimated GFR calculated by the three equations, CG, aMDRD and CKD EPI creatinine, though all the three equations did not correlate with 99mTc - DTPA GFR in this donor population. There was decline in 99mTc - DTPA GFR, by an average of 21.76 ml/ min/1.73 m2) (p 0.001). This loss of GFR is similar to that reported in literature 23,24. In our donors, remnant kidney increased its length, width and surface area (p 0.001). This compensatory increase in size did not correlate with the increase in remnant kidney 99mTc -DTPA GFR. This is in contrast to the observation by Yasuhito Funahashi et al25. Small study population, short median follow up period and failure to compare eGFR and measured GFR with 24 hour creatinine clearance are limltations of our study.

 

CONCLUSIONS

Post-operative complications were seen in 16.5% of our donors. Two (6.6%) had sub nephrotic proteinuria. Impaired fasting glucose was seen in 16.5% of our donors and was of concern. Hypertension was seen in 6.5% of our donors, which is similar to that seen in general population. So regular follow up of donors and insistence on life style modifications are of paramount importance. There was expected increase in measured GFR. There were no correlations between calculated and measured GFR values.

 

REFERENCES

  1. Biller , Gender imbalance in living organ donation, Medicine, Health care and Philosophy – 2002:5:194 – 202
  2. Zimmerman , Gender disparity in living kidney donation, AJKD – 2000:36:536-540 :Oct 2011.
  3. BlohmeI . Living donor nephrectomy: complication rate in 490 consecutive cases, Scand J Urol – 1992:26:149.
  4. Segev, Perioperative mortality and long – term survival following live kidney donation – JAMA 2010:303:959-966
  5. Tapson JS: Renal function and blood pressure after donor nephrectomy. ProcEur Dial Transplant AssocEur RenAssoc21: 580–587, 1985.
  6. Dunn JF: Living related kidney donors. A14-year experience.Ann Surg203: 637–643, 1986.
  7. Siebels M: Risks and complications in 160 living kidney donors who underwent nephroureterectomy. NephrolDial Transplant 18: 2648–2654, 2003.
  8. Wiesel M: Living donor nephrectomy: A 28-year experience at Heidelberg University. TransplantProc29: 2769, 1997.
  9. Rizvi SA: Living kidney donor follow-up in a dedicated clinic. Transplantation 79: 1247–1251, 2005.
  10. Natarajan: 20 years or more of follow-up of living kidney donors. Lancet 340: 807–810, 1992.
  11. Bertram l.Kasiske.A prospective controlled study of kidney donors: Baseline and 6-month follow-up.Am J Kidney Dis.2013 Sep; 62(3):577-586.
  12. H. N. Ibrahim. Diabetes after Kidney Donation.Am J Transplant. 2010 February; 10(2): 331–337.
  13. ImedHelal. Short- and Long-Term Outcomes of Kidney Donors:A Report from Tunisia.Saudi J Kidney Dis Transpl 2012;23(4):853-859.
  14. Williams SL: Long-term renal function in kidney donors: A comparison of donors and their siblings. Ann Intern Med 105: 1–8, 1986.
  15. Holdaas H, Leivestad T, Hartmann A, Bentdal Ø, Fauchald P. The Incidence of End-Stage Renal Disease (ESRD) in living donors. A 31 year follow-up of 1668 living donors in Norway. J Am SocNephrol 2001; 12: 895A.
  16. Anders Hartmann: The risk of living kidney donation. Nephrol Dial Transplant (2003) 18: 871–873.
  17. Ramcharan T: Long-term (20–37 years) follow-up of living kidney donors. Am J Transplant 2: 959–964, 2002.
  18. Talseth T: Long-term blood pressure and renal function in kidney donors. KidneyInt29: 1072–1076, 1986.
  19. Hakim RM: Hypertension and proteinuria: Long-term sequelae of uninephrectomy in humans. Kidney Int25: 930–936, 1984.
  20. Ellison MD: Living kidney donors in need of kidney transplants: A report from the organ procurement and transplantation network. Transplantation 74: 1349–1351, 2002.
  21. Fehrman-Ekholm I. Kidney donors live longer. Transplantation 1997; 64: 976–978.
  22. PoggioED :Demographic and clinical characters associated with GFR in living kidney donors – KI 75:2009:1079-1085.
  23. WH Bay: The living donor in kidney transplantation, Ann Intern Med 1987;106:719-2
  24. BieniaszM : The assessment of residual kidney function after living donor nephrectomy, Transplant Proceedings -2008:08:160.
  25. YasuhitoFunahashi: Relationship between RPV and single kidney GFR before and after donor nephrectomy, Urology–2010.



 



 




 



 


 


 

 


 



 



 





 




 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.